- Press Release
- U.S. Central Venous Catheter Market to Surpass US$ 1,332.2 Million by 2026
U.S. Central Venous Catheter Market to Surpass US$ 1,332.2 Million by 2026 - Coherent Market Insights
Published On : May 10, 2019
U.S. Central Venous Catheter Market, by Product Type (Peripherally Inserted Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter, and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double Lumen, and Multi Lumen), by Composition (Polyurethane, Polyethylene, and Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and Dialysis Procedure), and by End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics) was valued at US$ 825.9 million in 2018, and is projected to exhibit a CAGR of 6.2% over the forecast period (2018 – 2026).
Increasing prevalence of renal diseases and cancer is expected to augment the market growth Increasing prevalence of diseases that require long-term therapies such as cancer (chemotherapy) and end stage renal disease (dialysis) is expected to fuel growth of the U.S. central venous catheter market. According to the National Center for Chronic Disease Prevention and Health Promotion, 2017, around 30 million people or 15% of the U.S. adults were estimated to have chronic kidney. According to the World Health Organization (WHO), 2012, cancer is the second leading cause of morbidity and mortality worldwide, with around 14 million new cases registered in 2012. Furthermore, WHO stated that the number of new cases is expected to rise by around 70% by 2030. Also, in 2015, cancer was responsible for 8.8 million deaths globally
Browse 38 Market Data Tables and 34 Figures spread through 117 Pages and in-depth TOC on ‘U.S. Central Venous Catheter Market - U.S. Forecast to 2026, by Product Type (Peripherally Inserted Central Catheters (PICC), Implantable Ports, Tunneled Central Venous Catheter, and Non-tunneled Central Venous Catheter), by Design (Single Lumen, Double Lumen, and Multi Lumen), by Composition (Polyurethane, Polyethylene, and Silicon), by Procedure (Cardiovascular Procedure, Chemotherapy Procedure, and Dialysis Procedure), and by End User (Hospitals, Ambulatory Surgical Centers, and Specialty Clinics)
To know the latest trends and insights prevalent in the Central Venous Catheter Market, click the link below:
https://www.coherentmarketinsights.com/market-insight/us-central-venous-catheter-market-2610
Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance their product portfolio. For instance in July 2018, B. Braun Melsungen AG acquired bloodlines business of NxStage Medical, Inc. Similarly, in 2017, Becton, Dickinson, and Company acquired C.R. Bard, Inc. which created a new health care industry leader with approximately US$16 billion in annualized revenue
Key Takeaways of the Central Venous Catheter Market:
Joining thousands of companies around the world committed to making the Excellent Business Solutions.